HomeVBL › Filing
🔔 Get instant alerts when VBL files quarterly results on BSE Start free trial →

Press Release

Filed: 28 Jul 2026, 12:22 IST Exchange: BSE Category: Financial Results — Press Release
Press Release - Q2 & H1 CY2026 - Q2 revenue grew 20.4% YoY to Rs. 84.5bn; EBITDA up 17.2% to Rs. 23.4bn; PAT rose 15.1% to Rs. 15.3bn - H1 revenue increased 19.4% YoY to Rs. 150.3bn; EBITDA up 18.7% to Rs. 38.7bn; PAT up 16.9% to Rs. 24.0bn - India volumes grew 14.4% in Q2; international volumes up 38.4%, aided by Twizza acquisition - Extended PepsiCo bottling agreement in India to 2049, removing SPV restriction for operational flexibility - Entered franchise with Asahi Group for CALPIS brand launch in India; acquired Devyani Food Industries Kenya business - Interim dividend approved at Rs. 0.50/share (25% face value), cash outflow ~Rs. 1.69bn
Source: Original filing PDF — view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts BOT
🚨 VBL — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
✓✓ 6:47 PM
🎧
Instant audio summaries2-min AI concall recap delivered with every earnings alert
📊
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
🔍
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes

Add VBL to your watchlist — all of this, automated.

Sign in with Google
14-day Pro trial · No credit card · Cancel anytime

More on Varun Beverages Limited

Important. The summary above is generated automatically from Varun Beverages Limited's own public regulatory filing under SEBI LODR. Indian Stock Alerts is not a SEBI-registered Research Analyst or Investment Adviser. This page is informational, not investment advice, a recommendation to buy or sell any security, or any opinion about the company's business, governance or financial health. Always read the original filing before acting and consult a registered adviser for investment decisions.